Nephrotic Syndrome-Associated Hypercoagulopathy is Alleviated by Nuclear Receptor Agonist Therapy with both Pioglitazone and Glucocorticoids
A. P. Waller, S. Agrawal, K. J. Wolfgang, J. Kino, M. A. Chanley, W. E. Smoyer, B. A. Kerlin, Pediatric Nephrology Research Consortium (PNRC)
This paper shows that pioglitazone and glucocorticoids reduce proteinuria and improve hypercoagulopathy in nephrotic syndrome, both in rats and children.
bioRxiv · Jan 7, 2020Pathology